DETRUSITOL Side Effects

7017492-4 | Urinary Retention, Urinary Tract Disorder
on Sep 22, 2010 Female patient from UNITED KINGDOM , 21 years of age, was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: urinary retention, urinary tract disorder. Detrusitol dosage: 1 Mg, 1x/day. During the same period patient was treated with NITROFURANTOIN (Unk) (View Nitrofurantoin Review and Nitrofurantoin Label ).

7017468-7 | Urine Output Decreased
Patient was taking Detrusitol (View Usage). Patient had the following side effects: urine output decreased on Sep 22, 2010 from JAPAN Additional patient health information: Female patient , 89 years of age, . Detrusitol dosage: 2 Mg, 1x/day.

7017458-4 | Faeces Discoloured
Adverse event was reported on Sep 21, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 4mg Daily) . Location: JAPAN , 78 years of age, After Detrusitol was administered, patient had the following side effects: faeces discoloured.

6991882-8 | Photophobia, Vision Blurred, Visual Impairment, Vitreous Opacities
on Sep 07, 2010 Male patient from GERMANY , 76 years of age, weighting 165.3 lb, was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: photophobia, vision blurred, visual impairment, vitreous opacities. Detrusitol dosage: 4 Mg, 1x/day. During the same period patient was treated with ALFUZOSIN (10 Mg, 1x/day) (View Alfuzosin Review and Alfuzosin Label ), FLUVASTATIN (20 Mg, 1x/day) (View Fluvastatin Review and Fluvastatin Label ), METOPROLOL SUCCINATE (23.75 Mg, 2x/day (half Of 47.5 Mg Twice Daily)) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).


6971609-6 | Anticholinergic Syndrome, Dry Mouth
on Sep 06, 2010 Female patient from CZECH REPUBLIC , 43 years of age, was diagnosed with hypertonic bladder and was treated with Detrusitol (View Usage). Patient had the following side effects: anticholinergic syndrome, dry mouth. Detrusitol dosage: 4 Mg, 1x/day. During the same period patient was treated with TOVIAZ (8 Mg, 1x/day) (View Toviaz Review and Toviaz Label ).

6971556-X | Cerebrovascular Accident, Photophobia, Vision Blurred, Visual Impairment, Vitreous Opacities
Patient was taking Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: cerebrovascular accident, photophobia, vision blurred, visual impairment, vitreous opacities on Aug 27, 2010 from GERMANY Additional patient health information: Male patient , 76 years of age, weighting 165.3 lb, . Detrusitol dosage: 4 Mg, 1x/day. During the same period patient was treated with ALFUZOSIN (10 Mg, 1x/day) (View Alfuzosin Review and Alfuzosin Label ), FLUVASTATIN (20 Mg, 1x/day) (View Fluvastatin Review and Fluvastatin Label ), METOPROLOL SUCCINATE (23.75 Mg, 2x/day (half Of 47.5 Mg Twice Daily)) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

6969227-9 | Anticholinergic Syndrome, Dry Mouth
Adverse event was reported on Sep 02, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 4 Mg, 1x/day) was diagnosed with hypertonic bladder and. Location: CZECH REPUBLIC , 43 years of age, Patient experienced the following unwanted or unexpected effects: anticholinergic syndrome, dry mouth. During the same period patient was treated with TOVIAZ (8 Mg, 1x/day) (View Toviaz Review and Toviaz Label ).

6965342-4 | Bladder Spasm, Blood Pressure Increased, Myocardial Infarction
on Aug 25, 2010 Female patient from COLOMBIA , 62 years of age, was diagnosed with micturition urgency, mitral valve stenosis and was treated with Detrusitol (View Usage). Patient had the following side effects: bladder spasm, blood pressure increased, myocardial infarction. Detrusitol dosage: 4 Mg, 1x/day. During the same period patient was treated with UNIPRIL (View Unipril Review and Unipril Label ), BETALOC (View Betaloc Review and Betaloc Label ). Patient was hospitalized.

6964489-6 | Visual Acuity Reduced
on Aug 23, 2010 Male patient from JAPAN , 93 years of age, was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: visual acuity reduced. Detrusitol dosage: 4 Mg, 1x/day.

6964442-2 | Skin Odour Abnormal, Surgery, Urine Odour Abnormal
Patient was taking Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: skin odour abnormal, surgery (What is surgery?), urine odour abnormal on Aug 23, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, . Detrusitol dosage: 2 Mg, Daily. During the same period patient was treated with FLIVAS (Unk) (View Flivas Review and Flivas Label ). Patient was hospitalized.

6955488-9 | Face Oedema, Oedema Peripheral
Adverse event was reported on Aug 18, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 2 Mg, Unk) . Location: JAPAN , 75 years of age, Patient had the following side effects: face oedema, oedema peripheral. During the same period patient was treated with ARICEPT (Unk) (View Aricept Review and Aricept Label ), FUROSEMIDE (1.5 Df, Unk) (View Furosemide Review and Furosemide Label ).

6943488-4 | Oedema
on Aug 16, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with hypertonic bladder and was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: oedema. Detrusitol dosage: Unk.

6939949-4 | Cataract, Vision Blurred
on Aug 13, 2010 Male patient from GERMANY , 76 years of age, was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), vision blurred. Detrusitol dosage: 4 Mg, 1x/day.

6936201-8 | Muscle Spasms
Patient was taking Detrusitol (View Usage). Patient had the following side effects: muscle spasms on Aug 11, 2010 from SWEDEN Additional patient health information: Female patient , 68 years of age, weighting 209.0 lb, was diagnosed with hypertonic bladder and. Detrusitol dosage: 4 Mg, Unk. During the same period patient was treated with SOBRIL (Unk) (View Sobril Review and Sobril Label ), ACETAMINOPHEN (Unk) (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6925018-6 | Skin Odour Abnormal, Surgery, Urine Odour Abnormal
Adverse event was reported on Aug 05, 2010 by a Male patient taking Detrusitol (View Usage) (Dosage: 2 Mg, Daily) . Location: JAPAN , 77 years of age, After Detrusitol was administered, patient had the following side effects: skin odour abnormal, surgery (What is surgery?), urine odour abnormal. During the same period patient was treated with FLIVAS (Unk) (View Flivas Review and Flivas Label ). Patient was hospitalized.

6923114-0 | Gout
on Aug 06, 2010 Male patient from SWEDEN , 53 years of age, was diagnosed with incontinence and was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: gout (What is gout?). Detrusitol dosage: Unk. During the same period patient was treated with STILNOCT (Unk) (View Stilnoct Review and Stilnoct Label ), TRIMEPRAZINE TAB (Unk) (View Trimeprazine Tab Review and Trimeprazine Tab Label ), LITHIUM (Unk) (View Lithium Review and Lithium Label ).

6922814-6 | Affect Lability, Suicidal Ideation
on Aug 03, 2010 Female patient from GERMANY , 25 years of age, weighting 136.7 lb, was diagnosed with micturition disorder, multiple sclerosis (What is multiple sclerosis?), neuralgia and was treated with Detrusitol (View Usage). Patient had the following side effects: affect lability, suicidal ideation. Detrusitol dosage: 2 Mg, 2x/day. During the same period patient was treated with TYSABRI (300 Mg, Unk) (View Tysabri Review and Tysabri Label ), NEURONTIN (300/300/0/900mg/ Day) (View Neurontin Review and Neurontin Label ).

6918618-0 | Arthralgia
Patient was taking Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: arthralgia on Jul 30, 2010 from JAPAN Additional patient health information: Male patient , 90 years of age, weighting 99.21 lb, was diagnosed with hypertonic bladder, osteoarthritis (What is osteoarthritis?) and. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with LOXOPROFEN SODIUM (Unk) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), AMLODIPINE (5 Mg, Unk) (View Amlodipine Review and Amlodipine Label ), OMEPRAZOLE (10 Mg, Unk) (View Omeprazole Review and Omeprazole Label ).

6887531-X | Cystitis
Adverse event was reported on Jun 30, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 2 Mg, 1x/day) was diagnosed with hypertonic bladder, vascular insufficiency and. Location: COLOMBIA , 79 years of age, Patient experienced the following unwanted or unexpected effects: cystitis. During the same period patient was treated with CUMADIN (5 Mg, 1x/day) (View Cumadin Review and Cumadin Label ).

6878182-1 | Mass, Varicose Ulceration
on Jul 15, 2010 Male patient from COLOMBIA , 81 years of age, was diagnosed with diabetes mellitus, blood pressure abnormal and was treated with Detrusitol (View Usage). Patient had the following side effects: mass, varicose ulceration. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with METFORMIN (850 Mg, 2x/day) (View Metformin Review and Metformin Label ), INSULIN (24 Iu, 2x/day) (View Insulin Review and Insulin Label ), METOPROLOL (50 Mg, Unk) (View Metoprolol Review and Metoprolol Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6856588-4 | Arthralgia
on Jul 09, 2010 Male patient from JAPAN , 90 years of age, was diagnosed with hypertonic bladder, osteoarthritis (What is osteoarthritis?) and was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: arthralgia. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with LOXOPROFEN SODIUM (Unk) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ).

6848234-0 | Urinary Retention
Patient was taking Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: urinary retention on Jul 05, 2010 from JAPAN Additional patient health information: Male patient , 85 years of age, weighting 121.0 lb, was diagnosed with pollakiuria and. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), COBALTAMIN (View Cobaltamin Review and Cobaltamin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), FLIVAS (Unk) (View Flivas Review and Flivas Label ), HARNAL (Unk) (View Harnal Review and Harnal Label ). Patient was hospitalized.

6847920-6 | Visual Acuity Reduced
Adverse event was reported on Jul 07, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 2 Mg, 1x/day) was diagnosed with hypertonic bladder and. Location: COLOMBIA , 58 years of age, Patient had the following side effects: visual acuity reduced.

6836155-9 | Dyskinesia
on Jul 01, 2010 Female patient from TURKEY , 67 years of age, was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: dyskinesia. Detrusitol dosage: 2 Mg, 1x/day.

6826270-8 | Arthralgia
on Jun 28, 2010 Male patient from JAPAN , 90 years of age, was diagnosed with hypertonic bladder, osteoarthritis (What is osteoarthritis?) and was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with LOXOPROFEN SODIUM (Unk) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ).

6813594-3 | Bone Marrow Toxicity, Bronchopneumonia, Capillary Leak Syndrome, Cardiac Failure, Condition Aggravated, Dehydration, Hepatic Function Abnormal, Hypoalbuminaemia
Patient was taking Detrusitol (View Usage). Patient had the following side effects: bone marrow toxicity, bronchopneumonia, capillary leak syndrome, cardiac failure, condition aggravated, dehydration, hepatic function abnormal, hypoalbuminaemia on Jun 17, 2010 from GERMANY Additional patient health information: Male patient , 87 years of age, was diagnosed with incontinence, conjunctivitis, cardiac failure, hypertension, hyperuricaemia, thrombosis prophylaxis and. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with IBUPROFEN (600 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ), DEXA POLYSPECTRAN N (Unk) (View Dexa Polyspectran N Review and Dexa Polyspectran N Label ), CYNT (0.3 Mg, Unk) (View Cynt Review and Cynt Label ), TORASEMIDE (10 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), NOVODIGAL (0.2 Mg, 1x/day) (View Novodigal Review and Novodigal Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6810516-6 | Blood Pressure Increased
Adverse event was reported on Jun 24, 2010 by a Male patient taking Detrusitol (View Usage) (Dosage: 4 Mg, 1x/day) . Location: JAPAN , 65 years of age, After Detrusitol was administered, patient had the following side effects: blood pressure increased. During the same period patient was treated with FLIVAS (View Flivas Review and Flivas Label ).

6803369-3 | Arthralgia
on Jun 18, 2010 Male patient from JAPAN , 90 years of age, was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia. Detrusitol dosage: Unk.

6801840-1 | Bone Marrow Toxicity, Bronchopneumonia, Capillary Leak Syndrome, Cardiac Failure, Condition Aggravated, Dehydration, Hepatic Function Abnormal, Hypoalbuminaemia
on Jun 17, 2010 Male patient from GERMANY , 87 years of age, was diagnosed with incontinence, conjunctivitis, cardiac failure, hypertension, hyperuricaemia, thrombosis prophylaxis and was treated with Detrusitol (View Usage). Patient had the following side effects: bone marrow toxicity, bronchopneumonia, capillary leak syndrome, cardiac failure, condition aggravated, dehydration, hepatic function abnormal, hypoalbuminaemia. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with IBUPROFEN (600 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ), DEXA POLYSPECTRAN N (Unk) (View Dexa Polyspectran N Review and Dexa Polyspectran N Label ), CYNT (0.3 Mg, Unk) (View Cynt Review and Cynt Label ), TORASEMIDE (10 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), NOVODIGAL (0.2 Mg, 1x/day) (View Novodigal Review and Novodigal Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6801138-1 | Cystitis
Patient was taking Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: cystitis on Jun 22, 2010 from COLOMBIA Additional patient health information: Female patient , 79 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?), vascular insufficiency and. Detrusitol dosage: Unk. During the same period patient was treated with CUMADIN (5 Mg, 1x/day) (View Cumadin Review and Cumadin Label ).

6765641-5 | Bladder Catheter Permanent, Medical Device Complication
Adverse event was reported on May 19, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: 4 Mg, 1x/day) . Location: GERMANY , 76 years of age, Patient experienced the following unwanted or unexpected effects: bladder catheter permanent, medical device complication.

6747797-3 | Scrotal Ulcer
on May 19, 2010 Male patient from JAPAN , 92 years of age, was treated with Detrusitol (View Usage). Patient had the following side effects: scrotal ulcer. Detrusitol dosage: Unk. During the same period patient was treated with LEUPLIN (Unk) (View Leuplin Review and Leuplin Label ), PROSTAL (Unk) (View Prostal Review and Prostal Label ).

6742470-X | Stevens-johnson Syndrome
on May 13, 2010 Male patient from GERMANY , 87 years of age, was diagnosed with incontinence, cardiac failure, hypertension, hyperuricaemia, thrombosis prophylaxis, conjunctivitis and was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: stevens-johnson syndrome. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with IBUPROFEN (600 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ), CYNT (0.3 Mg, Unk) (View Cynt Review and Cynt Label ), TORASEMIDE (10 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), NOVODIGAL (0.2 Mg, 1x/day) (View Novodigal Review and Novodigal Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), DEXA POLYSPECTRAN N (Unk) (View Dexa Polyspectran N Review and Dexa Polyspectran N Label ). Patient was hospitalized.

6724549-1 | Face Oedema, Oedema Peripheral
Patient was taking Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, oedema peripheral on May 03, 2010 from GERMANY Additional patient health information: Female patient , 72 years of age, weighting 174.2 lb, was diagnosed with urinary incontinence (What is urinary incontinence?) and. Detrusitol dosage: 1 Tablet Daily. During the same period patient was treated with LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (Unk) (View Losartan Potassium And Hydrochlorothiazide Review and Losartan Potassium And Hydrochlorothiazide Label ), PRESOMEN (Unk) (View Presomen Review and Presomen Label ), L THYROXIN ^HENNING BERLIN^ (50 Mg, 1x/day) (View L-thyroxin ^henning Berlin^ Review and L-thyroxin ^henning Berlin^ Label ), DICLOFENAC ^RATIOPHARM^ (100 Mg, 1x/day) (View Diclofenac ^ratiopharm^ Review and Diclofenac ^ratiopharm^ Label ), ACTOS (30 Mg, Unk) (View Actos Review and Actos Label ), OXAZEPAM RATIOPHARM (10 Mg, Unk) (View Oxazepam-ratiopharm Review and Oxazepam-ratiopharm Label ).

6722600-6 | Stevens-johnson Syndrome
Adverse event was reported on Apr 28, 2010 by a Male patient taking Detrusitol (View Usage) (Dosage: 2 Mg, 1x/day) was diagnosed with incontinence, cardiac failure, hypertension, hyperuricaemia, thrombosis prophylaxis, conjunctivitis and. Location: GERMANY , 87 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with IBUPROFEN (600 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ), CYNT (0.3 Mg, Unk) (View Cynt Review and Cynt Label ), TORASEMIDE (10 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), NOVODIGAL (0.2 Mg, 1x/day) (View Novodigal Review and Novodigal Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), DEXA POLYSPECTRAN N (Unk) (View Dexa Polyspectran N Review and Dexa Polyspectran N Label ). Patient was hospitalized.

6716252-9 | Stevens-johnson Syndrome
on Apr 27, 2010 Male patient from GERMANY , 87 years of age, was diagnosed with incontinence, pain (What is pain?), cardiac failure, hypertension, hyperuricaemia, thrombosis prophylaxis, conjunctivitis and was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: stevens-johnson syndrome. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with IBUPROFEN (600 Mg, Unk) (View Ibuprofen Review and Ibuprofen Label ), CYNT (0.3 Mg, Unk) (View Cynt Review and Cynt Label ), TORASEMIDE (10 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), NOVODIGAL (0.2 Mg, 1x/day) (View Novodigal Review and Novodigal Label ), ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), ASPIRIN (100 Mg, Unk) (View Aspirin Review and Aspirin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), DEXA POLYSPECTRAN N (Unk) (View Dexa Polyspectran N Review and Dexa Polyspectran N Label ). Patient was hospitalized.

6686309-X | Bladder Discomfort, Cystitis
on Apr 13, 2010 Female patient from IRELAND , 64 years of age, was diagnosed with pollakiuria and was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: bladder discomfort, cystitis. Detrusitol dosage: Unk. During the same period patient was treated with CRESTOR (Unk) (View Crestor Review and Crestor Label ).

6684955-0 | Gastrointestinal Tube Insertion
Patient was taking Detrusitol (View Usage). Patient had the following side effects: gastrointestinal tube insertion on Feb 22, 2010 from IRELAND Additional patient health information: Female patient , 65 years of age, was diagnosed with hypertonic bladder and. Detrusitol dosage: 4 Mg, 1x/day.

6676102-6 | Joint Range Of Motion Decreased, Movement Disorder, Muscular Weakness
Adverse event was reported on Mar 31, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: Unk) . Location: AUSTRALIA , child 9 years of age, After Detrusitol was administered, patient had the following side effects: joint range of motion decreased, movement disorder (What is movement disorder?), muscular weakness.

6656477-4 | Blood Pressure Decreased
on Mar 23, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hypertonic bladder and was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased. Detrusitol dosage: 4 Mg/day. During the same period patient was treated with HOLIN V (1 Tab/day, Every Other Day) (View Holin-v Review and Holin-v Label ), ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), METHYCOBAL (Unk) (View Methycobal Review and Methycobal Label ).

6656004-1 | Dry Mouth, Hypertonic Bladder, Micturition Urgency, Urogram Abnormal
on Mar 17, 2010 Male patient from BRAZIL , 60 years of age, weighting 154.3 lb, was diagnosed with hypertonic bladder and was treated with Detrusitol (View Usage). Patient had the following side effects: dry mouth, hypertonic bladder, micturition urgency, urogram abnormal. Detrusitol dosage: 2 Mg, 2x/day, Every 12 Hours. During the same period patient was treated with OXYBUTYNIN (5 Mg, 3x/day, Every 8 Hours) (View Oxybutynin Review and Oxybutynin Label ), SIMVASTATIN (20 Mg, Daily) (View Simvastatin Review and Simvastatin Label ).

6646021-X | Disorientation, Insomnia, Somnolence, Urinary Tract Infection
Patient was taking Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: disorientation, insomnia, somnolence, urinary tract infection (What is urinary tract infection?) on Mar 15, 2010 from GERMANY Additional patient health information: Female patient , 88 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?), prophylaxis against gastrointestinal ulcer, osteoporosis (What is osteoporosis?), back pain (What is back pain?) and. Detrusitol dosage: 2 Mg In The Morning And 2mg In The Evening. During the same period patient was treated with PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), DIDRONEL KIT ^HOECHST^ (View Didronel-kit ^hoechst^ Review and Didronel-kit ^hoechst^ Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), GINSENG (View Ginseng Review and Ginseng Label ), GINGIUM (View Gingium Review and Gingium Label ).

6645097-3 | Amnesia, Malaise
Adverse event was reported on Mar 11, 2010 by a Male patient taking Detrusitol (View Usage) (Dosage: 4 Mg, Unk) . Location: JAPAN , 78 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, malaise. During the same period patient was treated with ODYNE (View Odyne Review and Odyne Label ), OPALMON (View Opalmon Review and Opalmon Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ).

6644672-X | Mass, Varicose Ulceration
on Mar 12, 2010 Male patient from COLOMBIA , 81 years of age, was diagnosed with diabetes mellitus, blood pressure abnormal and was treated with Detrusitol (View Usage). Patient had the following side effects: mass, varicose ulceration. Detrusitol dosage: 2 Mg, 1x/day. During the same period patient was treated with METFORMIN (850 Mg, 2x/day) (View Metformin Review and Metformin Label ), INSULIN (24 Iu, 2x/day) (View Insulin Review and Insulin Label ), METOPROLOL (50 Mg, Unk) (View Metoprolol Review and Metoprolol Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6642200-6 | Blood Pressure Decreased
on Mar 08, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hypertonic bladder and was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: blood pressure decreased. Detrusitol dosage: 4 Mg/day. During the same period patient was treated with HOLIN V (1 Tab/day, Every Other Day) (View Holin-v Review and Holin-v Label ), ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), METHYCOBAL (Unk) (View Methycobal Review and Methycobal Label ).

6628329-7 | Post Procedural Haemorrhage
Patient was taking Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural haemorrhage on Mar 03, 2010 from IRELAND Additional patient health information: Male patient , 73 years of age, . Detrusitol dosage: Unk.

6605180-5 | Blood Pressure Decreased
Adverse event was reported on Feb 22, 2010 by a Female patient taking Detrusitol (View Usage) (Dosage: Unk) was diagnosed with hypertonic bladder and. Location: JAPAN , 70 years of age, Patient had the following side effects: blood pressure decreased. During the same period patient was treated with ALFACALCIDOL (Unk) (View Alfacalcidol Review and Alfacalcidol Label ), METHYCOBAL (Unk) (View Methycobal Review and Methycobal Label ), HOLIN V (1 Tab/day Every Other Day) (View Holin-v Review and Holin-v Label ).

6596301-1 | Blood Pressure Increased
on Feb 12, 2010 Male patient from JAPAN , 63 years of age, was treated with Detrusitol (View Usage). After Detrusitol was administered, patient had the following side effects: blood pressure increased. Detrusitol dosage: Unk. During the same period patient was treated with FLIVAS (View Flivas Review and Flivas Label ).

6582765-6 | Human T-cell Lymphotropic Virus Type I Infection, Thrombosis
on Feb 05, 2010 Female patient from BRAZIL , 71 years of age, weighting 105.8 lb, was diagnosed with neurogenic bladder and was treated with Detrusitol (View Usage). Patient experienced the following unwanted or unexpected effects: human t-cell lymphotropic virus type i infection, thrombosis. Detrusitol dosage: 2 Mg, 2x/day. During the same period patient was treated with MACRODANTINA (Unk) (View Macrodantina Review and Macrodantina Label ), GABAPENTIN (Unk) (View Gabapentin Review and Gabapentin Label ).

6576977-5 | Renal Impairment
Patient was taking Detrusitol (View Usage). Patient had the following side effects: renal impairment on Dec 07, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 79 years of age, was diagnosed with urinary incontinence (What is urinary incontinence?) and. Detrusitol dosage: 8 Mg, 1x/day. During the same period patient was treated with AMLODIPINE (10 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ), FINASTERIDE (5 Mg, 1x/day) (View Finasteride Review and Finasteride Label ), TAMSULOSIN (400 Ug, 1x/day) (View Tamsulosin Review and Tamsulosin Label ). Patient was hospitalized.